A 3′-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

Autor: Chung, C.H. *, Lee, J.W., Slebos, R.J., Howard, J.D., Perez, J., Kang, H., Fertig, E.J., Considine, M., Gilbert, J., Murphy, B.A., Nallur, S., Paranjape, T., Jordan, R.C., Garcia, J., Burtness, B., Forastiere, A.A., Weidhaas, J.B.
Zdroj: In Annals of Oncology November 2014 25(11):2230-2236
Databáze: ScienceDirect